Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 9Sarcoma 6Genitourinary 6Gastrointestinal 5Thoracic 3Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Head & Neck 2Dermatologic 2Other solid neoplasm 1NET 1Gynecologic 1Endocrine 1

Conditions

Myelodysplastic Syndromes 175Leukemia, Myeloid, Acute 157Myeloproliferative Disorders 74Leukemia, Myelogenous, Chronic, BCR-ABL Positive 73Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Primary Myelofibrosis 52Leukemia, Myelomonocytic, Chronic 45Lymphoma, Non-Hodgkin 39Leukemia 28Polycythemia Vera 25Hodgkin Disease 25Thrombocythemia, Essential 22Myelodysplastic-Myeloproliferative Diseases 22Multiple Myeloma 21Leukemia, Lymphocytic, Chronic, B-Cell 20Leukemia, Biphenotypic, Acute 19Hematologic Neoplasms 19Neoplasms 17Anemia, Refractory, with Excess of Blasts 15Leukemia, Myeloid, Chronic-Phase 14Sarcoma 13Histiocytosis, Langerhans-Cell 13Glioma 13Recurrence 12Neuroblastoma 12Hematologic Diseases 12Wilms Tumor 11Rhabdoid Tumor 11Osteosarcoma 11Neuroectodermal Tumors, Primitive, Peripheral 11

Interventions

fludarabine phosphate 1fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × Myeloid × 90 days × Clear all
NCT05092451 2026-05-06

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
80 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Plasma Cell, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Germ Cell and Embryonal, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell

NCT01890486 2026-04-13

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Wake Forest University Health Sciences

Recruiting
2,000 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Germ Cell and Embryonal, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡